MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease

M. Panchwadkar, P. Rane, D. Khatri, V. Undale (Pune, India)

Meeting: 2018 International Congress

Abstract Number: 201

Keywords: Behavioral abnormalities, Parkinsonism, Rotenone

Session Information

Date: Saturday, October 6, 2018

Session Title: Neuropharmacology

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: In the current study we have evaluated possible synergistic neuroprotective effect of two Poly-Phenols from Curcumin and Mucuna Prurience. The combine treatment of Curcumin and Methanolic Extract of Mucuna prurience seed was explored for their possible neuroprotective role against rotenone induced behaviourial, mitochondrial and oxidative dysfunction in mice model of Parkinson’s disease.

Background: Curcumin and extract of Mucuna prurience are natural polyphenolic, highly effective bioactive compounds. Mucuna prurience is popular Indian medicinal plant which has long been used in ayurvedic system of medicine. They revealed numerous biological and pharmacological activities with effective antioxidant, cardiovascular disease, anticancer, anti-inflammatory effects, antidiabetic, anticholestrolemic, aphrodisiac and neuroprotective properties in cell cultures and different animal models.

Methods: Chronic 21 days administration of rotenone (1 mg/kg i.p.) significantly reduced behavioral parameter (Memory, learning and locomotor activity), antioxidant status (Decreased activity of lipid peroxidation, superoxide dismutase, catalase and reduced glutathione level) and mitochondrial Complex-II-Succinate Dehydrogenase (SDH), Complex III- MTT (3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyl-H-tetrazolium bromide) enzymes activities as compared to normal group of mice.

Results: Combination of Curcumin and extract Mucuna prurience treatment for 21 days showed significant (P<0.001) improvement in behavior parameter, oxidative damage and mitochondrial enzyme complex activities as compared to rotenone-treated (negative control) group. The result of present investigation shows that Curcumin and extract of Mucuna prurience in combination restored the motor deficiency and increases the antioxidant and neuroprotective activities.

Conclusions: The finding of present study demonstrates that the role of both Curcumin and extract of Mucuna prurience potential against rotenone-induced Parkinson’s in mice and could serve as therapeutic strategies for the management and prevention of Parkinson’s Disease.

References: 1. Phom L. et al., 2014. Curcumin neuroprotective efficacy in Drosophila model of Idiopathic Parkinson’s disease is phase specific; implication of its therapeutic effectiveness. Rejuvnation Research 17, 481-489. 2. Bala V. Manyam, Muralikrishnan Dhanasekaran 2004. Neuroprotective Effects of the Antiparkinson Drug Mucuna pruriens. phytotherapy research, 18, 706–712. 3. Ramkumar M. et al., 2017. Neuroprotective effect of Desmethoxycurcumin, a natural derivative of curcumin on rotenone induced neurotoxicity in SH-SY 5Y neuroblastoma cell. BMC complementary and alternative medicine, 17 (217), 1-11.

To cite this abstract in AMA style:

M. Panchwadkar, P. Rane, D. Khatri, V. Undale. Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-a-combination-of-curcumin-and-mucuna-prurience-in-rotenone-induced-mice-model-of-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-a-combination-of-curcumin-and-mucuna-prurience-in-rotenone-induced-mice-model-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley